Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

SNS-314 shows consistent and dose-dependent antitumor activity in mice

March 13, 2007

Pemetrexed combinations found highly effective against NSCLC cells

March 13, 2007

Array BioPharma reports on anticancer activity of its p38 MAPK inhibitor

March 13, 2007

Biomarker studies test AZD-0530's potential in managing bone metastasis

March 13, 2007

Positive data reported from phase Ib study of TASQ

March 13, 2007

Natural toxin shows potential against prostate cancer in vitro

March 13, 2007

Claudins validated as targets in ovarian cancer

March 12, 2007

N-69: a novel nucleoside analogue potentially useful in melanoma therapy

March 12, 2007

Azixa begins phase II for glioblastoma multiforme

March 12, 2007

AS-1404 with carboplatin and paclitaxel shows good response rate in NSCLC

March 9, 2007

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...